Skorpios Trust - 04 Jun 2025 SCHEDULE 13D/A Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

Filing Manager
Skorpios Trust
Reporting Manager
Montrago Trustees Ltd
Security
Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
STOK
Shares outstanding
54.3M shares
Disclosed Ownership
3.91M shares
Ownership
7.2%
Form type
SCHEDULE 13D/A
Filing time
06 Jun 2025, 16:23:10 UTC
Date of event
04 Jun 2025
Previous filing
27 Dec 2024
Next filing
23 Jun 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Blue Horizon Enterprise Ltd 5.4% 2.97M 0 2.97M /s/ Eleni Constantinou Kyriacou Eleni Constantinou Kyriacou, Director 0001869057
Ezbon International Ltd 1.7% 939K 0 939K /s/ Eleni Constantinou Kyriacou Eleni Constantinou Kyriacou, Director 0001869027
Montrago Trustees Ltd 7.2% 3.91M 0 3.91M /s/ Androulla Papadopoulou Androulla Papadopoulou, Director 0001869331
Skorpios Trust 7.2% 3.91M 0 3.91M /s/ Androulla Papadopoulou Androulla Papadopoulou, Director 0001869333